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What are viral hemorrhagic fevers? 
Viral hemorrhagic fevers (VHFs) refer to a group of illnesses that are caused by several distinct families of 
viruses. In general, the term "viral hemorrhagic fever" is used to describe a severe multisystem syndrome 
(multisystem in that multiple organ systems in the body are affected).  Characteristically, the overall vascular 
system is damaged, and the body's ability to regulate itself is impaired.  These symptoms are often 
accompanied by hemorrhage (bleeding); however, the bleeding is itself rarely life-threatening. While some 
types of hemorrhagic fever viruses can cause relatively mild illnesses, many of these viruses cause severe, 
life-threatening disease. 
 
The Special Pathogens Branch (SPB) primarily works with hemorrhagic fever viruses that are classified as 
biosafety level four (BSL-4) pathogens. A list of these viruses appears in the SPB disease information index. 
The Division of Vector-Borne Infectious Diseases, also in the National Center for Infectious Diseases, works 




How are hemorrhagic fever viruses grouped? 
VHFs are caused by viruses of four distinct families: arenaviruses, filoviruses, bunyaviruses, and flaviviruses. 
Each of these families share a number of features: 
 
· They are all RNA viruses, and all are covered, or enveloped, in a fatty (lipid) coating.  
· Their survival is dependent on an animal or insect host, called the natural reservoir.  
· The viruses are geographically restricted to the areas where their host species live.  
· Humans are not the natural reservoir for any of these viruses. Humans are infected when they come 
into contact with infected hosts. However, with some viruses, after the accidental transmission from the 
host, humans can transmit the virus to one another.  
· Human cases or outbreaks of hemorrhagic fevers caused by these viruses occur sporadically and 
irregularly. The occurrence of outbreaks cannot be easily predicted.  
· With a few noteworthy exceptions, there is no cure or established drug treatment for VHFs.  
 




What carries viruses that cause viral hemorrhagic fevers? 
Viruses associated with most VHFs are zoonotic. This means that these viruses naturally reside in an animal 
reservoir host or arthropod vector. They are totally dependent on their hosts for replication and overall survival. 
For the most part, rodents and arthropods are the main reservoirs for viruses causing VHFs. The 
multimammate rat, cotton rat, deer mouse, house mouse, and other field rodents are examples of reservoir 
hosts. Arthropod ticks and mosquitoes serve as vectors for some of the illnesses. However, the hosts of some 






Where are cases of viral hemorrhagic fever found? 
Taken together, the viruses that cause VHFs are distributed over much of the globe. However, because each 
virus is associated with one or more particular host species, the virus and the disease it causes are usually 
seen only where the host species live(s). Some hosts, such as the rodent species carrying several of the New 
World arenaviruses, live in geographically restricted areas. Therefore, the risk of getting VHFs caused by these 
viruses is restricted to those areas. Other hosts range over continents, such as the rodents that carry viruses 
which cause various forms of hantavirus pulmonary syndrome (HPS) in North and South America, or the 
different set of rodents that carry viruses which cause hemorrhagic fever with renal syndrome (HFRS) in 
Europe and Asia. A few hosts are distributed nearly worldwide, such as the common rat. It can carry Seoul 
virus, a cause of HFRS; therefore, humans can get HFRS anywhere where the common rat is found. 
 
While people usually become infected only in areas where the host lives, occasionally people become infected 
by a host that has been exported from its native habitat. For example, the first outbreaks of Marburg 
hemorrhagic fever, in Marburg and Frankfurt, Germany, and in Yugoslavia, occurred when laboratory workers 
handled imported monkeys infected with Marburg virus. Occasionally, a person becomes infected in an area 
where the virus occurs naturally and then travels elsewhere. If the virus is a type that can be transmitted further 
by person-to-person contact, the traveler could infect other people. For instance, in 1996, a medical 
professional treating patients with Ebola hemorrhagic fever (Ebola HF) in Gabon unknowingly became 
infected. When he later traveled to South Africa and was treated for Ebola HF in a hospital, the virus was 
transmitted to a nurse. She became ill and died. Because more and more people travel each year, outbreaks 




How are hemorrhagic fever viruses transmitted? 
Viruses causing hemorrhagic fever are initially transmitted to humans when the activities of infected reservoir 
hosts or vectors and humans overlap. The viruses carried in rodent reservoirs are transmitted when humans 
have contact with urine, fecal matter, saliva, or other body excretions from infected rodents. The viruses 
associated with arthropod vectors are spread most often when the vector mosquito or tick bites a human, or 
when a human crushes a tick. However, some of these vectors may spread virus to animals, livestock, for 
example. Humans then become infected when they care for or slaughter the animals. 
 
Some viruses that cause hemorrhagic fever can spread from one person to another, once an initial person has 
become infected. Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic fever viruses are examples. This 
type of secondary transmission of the virus can occur directly, through close contact with infected people or 
their body fluids. It can also occur indirectly, through contact with objects contaminated with infected body 
fluids. For example, contaminated syringes and needles have played an important role in spreading infection in 
outbreaks of Ebola hemorrhagic fever and Lassa fever. 
 
 
What are the symptoms of viral hemorrhagic fever illnesses? 
Specific signs and symptoms vary by the type of VHF, but initial signs and symptoms often include marked 
fever, fatigue, dizziness, muscle aches, loss of strength, and exhaustion. Patients with severe cases of VHF 
often show signs of bleeding under the skin, in internal organs, or from body orifices like the mouth, eyes, or 
ears. However, although they may bleed from many sites around the body, patients rarely die because of blood 
loss. Severely ill patient cases may also show shock, nervous system malfunction, coma, delirium, and 
seizures. Some types of VHF are associated with renal (kidney) failure. 
 
 
How are patients with viral hemorrhagic fever treated? 
Patients receive supportive therapy, but generally speaking, there is no other treatment or established cure for 
VHFs. Ribavirin, an anti-viral drug, has been effective in treating some individuals with Lassa fever or HFRS. 




How can cases of viral hemorrhagic fever be prevented and controlled? 
With the exception of yellow fever and Argentine hemorrhagic fever, for which vaccines have been developed, 
no vaccines exist that can protect against these diseases. Therefore, prevention efforts must concentrate on 
avoiding contact with host species. If prevention methods fail and a case of VHF does occur, efforts should 
focus on preventing further transmission from person to person, if the virus can be transmitted in this way.  
Because many of the hosts that carry hemorrhagic fever viruses are rodents, disease prevention efforts 
include: 
· controlling rodent populations;  
· discouraging rodents from entering or living in homes or workplaces;  
· encouraging safe cleanup of rodent nests and droppings.  
 
For hemorrhagic fever viruses spread by arthropod vectors, prevention efforts often focus on community-wide 
insect and arthropod control. In addition, people are encouraged to use insect repellant, proper clothing, 
bednets, window screens, and other insect barriers to avoid being bitten. 
 
For those hemorrhagic fever viruses that can be transmitted from one person to another, avoiding close 
physical contact with infected people and their body fluids is the most important way of controlling the spread 
of disease. Barrier nursing or infection control techniques include isolating infected individuals and wearing 
protective clothing. Other infection control recommendations include proper use, disinfection, and disposal of 
instruments and equipment used in treating or caring for patients with VHF, such as needles and 
thermometers. 
 
In conjunction with the World Health Organization, CDC has developed practical, hospital-based guidelines, 
titled: Infection Control for Viral Haemorrhagic Fevers In the African Health Care Setting.  The manual can help 
health-care facilities recognize cases and prevent further hospital-based disease transmission using locally 
available materials and few financial resources. 
 
 
What needs to be done to address the threat of viral hemorrhagic fevers? 
Scientists and researchers are challenged with developing containment, treatment, and vaccine strategies for 
these diseases. Another goal is to develop immunologic and molecular tools for more rapid disease diagnosis, 
and to study how the viruses are transmitted and exactly how the disease affects the body (pathogenesis). A 
third goal is to understand the ecology of these viruses and their hosts in order to offer preventive public health 
advice for avoiding infection. 
 
